SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001140361-23-057146
Filing Date
2023-12-11
Accepted
2023-12-11 16:01:29
Documents
4
Period of Report
2023-12-28

Document Format Files

Seq Description Document Type Size
1 DEF 14A ny20013066x2_def14a.htm DEF 14A 231664
2 logo_eiger.jpg GRAPHIC 31688
3 ny20013066x2_pc01.jpg GRAPHIC 572614
4 ny20013066x2_pc02.jpg GRAPHIC 466175
  Complete submission text file 0001140361-23-057146.txt   1706149
Mailing Address 2155 PARK BOULEVARD PALO ALTO CA 94306
Business Address 2155 PARK BOULEVARD PALO ALTO CA 94306 650-279-9845
Eiger BioPharmaceuticals, Inc. (Filer) CIK: 0001305253 (see all company filings)

IRS No.: 361004130 | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-36183 | Film No.: 231478108
SIC: 2836 Biological Products, (No Diagnostic Substances)